Study | Sample Size* | Randomized Method | Treatment | Control | Course | Outcome Measurements | Follow-Up | Safety | Assessment | |
---|---|---|---|---|---|---|---|---|---|---|
(Male/Female) | of Bias** | |||||||||
Chen 2012 [46] | 16/20 | 14/22 | NR | SV | Diazepam | 30 Days | Effective rate | NR | NR | ?,?,-,?,+,?,? |
Chyi Lo 2013 [58] | 0/14 | 0/13 | Random Number Table | MP | Sham AA | >21 Days | PSG, PSQI | NR | NR | +,?,+,-,+,+,- |
Hisghman 2006 [60] | 1/10 | 1/9 | Computer Software | MP | Stainless Steel Pellet | 17 Days | PSQI Sleep Diary, ISI, MOS SF-12, TEQ | 12 Days | NR | +,+,+,?,+,+,- |
Hu 2010 [47] | 22/10 | 18/13 | NR | SV | Diazepam | 28 Days | Effective rate, PQSI, AIS | NR | NR | +,-,-,-,+,-,- |
Jiang 2010 [48] | 14/49 | 10/52 | Random Number Table | SV | Sham AA | 20-25 Days | PSQI | NR | NR | +,-,+,-,+,+,- |
Jin 2012 [49] | 13/27 | 15/25 | NR | MP | Estazolam | 7-14 Days | Effective rate, TESS | NR | Reported | +,-,-,?,?,?,? |
Lin 2007 [59] | 16/14 | 17/13 | NR | SV | Sham AA | 51 Days | Effective rate, EEG, PQSI | NR | NR | ?,?,+,?,+,-,- |
Liu 2008 [50] | 26/74 | 37/63 | Computer Software | MP | Sham AA | 30 Days | PSQI | NR | NR | +,?,+,?,-,-,- |
Luo 2010 [51] | 11/10 | 9/12 | NR | SV | Estazolam | 30 Days | Effective rate, PQSI | NR | NR | ?,?,-,?,-,-, - |
Pi 2012 [52] | 71/79 | 75/75 | Computer Software | SV | Sham AA | 8 Weeks | PSQI | NR | NR | +,-,+,-,-,-,- |
Suen 2002 [57] | 10/110*** | NR | MP/SV | Junci Medulla Attachment | 21 Days | Sleep Diary, Actigraphy | 0.5-1 Year | NR | ?,?,+,+,+,-,- | |
Wang 1993 [53] | 10/20 | 12/18 | NR | SV | Diazepam | 20 Days | Effective rate, SCL-90 | NR | Reported | ?,?,-,?,+,-,- |
Wang 2002 [54] | 17/13 | 14/16 | NR | MP | Diazepam | 3-10 Days | Effective rate | NR | NR | ?,?,-,?,+,-,- |
Wei 2010 [55] | 22/14 | 21/15 | NR | NR | Estazolam | 28 Days | Effective rate, Sleep Efficiency | NR | Reported | ?,?,-,?,?,?,- |
Zhang 2008 [56] | 10/58 | 8/50 | Random Number Table | MP | Estazolam | 18 Days | Effective rate | NR | Reported | ?,?,-,?,?,?,- |